@lewm You write, "Pradax is contraindicated in patients with AF, per an FDA directive"
But I read the product monograph differently. It reads,
PRADAXA (dabigatran etexilate) is indicated for the:
prevention of stroke and systemic embolism in patients with atrial fibrillation, in whom anticoagulation is appropriate
Were you perhaps thinking of this?
Concomitant use of PRADAXA with an antithrombotic is not recommended for prevention of cardiogenic thromboembolic stroke in AF patients.